Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Ulcer 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Stomatitis 1Stomach Neoplasms 1Radiation Pneumonitis 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Neuroma 1Myeloproliferative Disorders 1Median Neuropathy 1Lung Neoplasms 1Lung Diseases, Interstitial 1Hand Injuries 1Disease 1Carpal Tunnel Syndrome 1Breast Neoplasms 1

Interventions

ruxolitinib 6Specimen Handling 6Stem Cell Transplantation 5Cyclophosphamide 4fludarabine 3Mycophenolic Acid 3Biopsy 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3Whole-Body Irradiation 2Tacrolimus 2Sirolimus 2Methotrexate 2Melphalan 2Hematopoietic Stem Cell Transplantation 2Blood Component Removal 2thymoglobulin 1talazoparib 1tagraxofusp 1reparixin 1poly ICLC 1piperine 1pegylated granulocyte colony-stimulating factor 1merphos 1letermovir 1fludarabine phosphate 1fedratinib 1demethoxycurcumin 1daratumumab 1bomedemstat 1axatilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Primary Myelofibrosis × Acetylcysteine × Clear all
NCT05123365 2026-03-10

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

University of California, Irvine

Phase 1/2 Recruiting
27 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡